Citation: | WANG Hua-jun, QIAO Chen, ZHAO Rong, YIN Jiang-ning. Study on the Mechanism of Circular-Icaritin Against Glucocorticoid-Induced Osteoporosis[J]. Journal of Nanjing University of traditional Chinese Medicine, 2019, 35(6): 708-713. |
[1] |
FIROOZABADI R, CROSS WW, KRIEG JC, et al. Acetabular fractures in the senior population-epidemiology, mortality and treatments[J]. Arch Bone Jt Surg, 2017, 5(2): 96-102.
|
[2] |
BUCKLEY L, GUYATT G, FINK HA, et al. 2017 American college of rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis [J]. Arthritis Care Res, 2017, 69: 1095-1110.
|
[3] |
XI L, DE FALCO P, BARBIERI E, et al. Bone matrix development in steroid-induced osteoporosis is associated with a consistently reduced fibrillar stiffness linked to altered bone mineral quality[J]. Acta Biomater, 2018, 76: 295-307.
|
[4] |
WINBLAD L, LARSEN CG, HAKANSSON K, et al. The risk of osteoporosis in oral steroid treatment for nasal polyposis: A systematic review[J]. Rhinology, 2017, 55(3): 195-201.
|
[5] |
MAAS BM, WANG J, COONER F, et al. Bone mineral density to assess pediatric bone health in drug development[J]. Ther Innov Regul Sci, 2017, 51(6): 756-760.
|
[6] |
FAN S, GAO X, CHEN P, et al. Myricetin ameliorates glucocorticoid-induced osteoporosis through the ERK signaling pathway[J]. Life Sci, 2018, 207: 205-211.
|
[7] |
LIU S, FANG T, YANG L, et al. Gastrodin protects MC3T3-E1 osteoblasts from dexamethasone-induced cellular dysfunction and promotes bone formation via induction of the NRF2 signaling pathway[J]. Int J Mol Med, 2018, 41(4):2059-2069.
|
[8] |
HE H, WANG C, TANG Q, et al. Possible mechanisms of prednisolone-induced osteoporosis in zebrafish larva[J].Biomed Pharmacother, 2018, 101:981-987.
|
[9] |
JIANG J, LI J, JIA X. The antiosteoporotic activity of central-icaritin (CIT) on bone metabolism of ovariectomized rats[J]. Molecules, 2014, 19(11):18690-18704.
|
[10] |
JIANG J, XIAO S, XU X, et al. Isomeric flavonoid aglycones derived from Epimedii Folium exerted different intensities in anti-osteoporosis through OPG/RANKL protein targets[J]. Int Immunopharmacol, 2018, 62:277-286.
|
[11] |
LIU L, TAO W, PAN W, et al. Hydroxysafflor yellow a promoted bone mineralization and inhibited bone resorption which reversed glucocorticoids-induced osteoporosis[J]. Biomed Res Int, 2018, 2018:6762146.
|
[12] |
VAREA O, AREVALO MA, GARRIDO JJ, et al. Interaction of estrogen receptors with insulin-like growth factor-I and Wnt signaling in the nervous system[J]. Steroids, 2010, 75(8/9):565-569.
|
[13] |
LIU K, JING Y, ZHANG W, et al. Silencing miR-106b accelerates osteogenesis of mesenchymal stem cells and rescues against glucocorticoid-induced osteoporosis by targeting BMP2[J]. Bone, 2017, 97:130-138.
|
[14] |
YONGTAO Z, KUNZHENG W, JINGJING Z, et al. Glucocorticoids activate the local renin-angiotensin system in bone: possible mechanism for glucocorticoid-induced osteoporosis[J]. Endocrine, 2014, 47(2):598-608.
|
[15] |
LI B, JIANG Y, SUN J, et al. MR spectroscopy for assessing the effects of oxytocin on marrow adipogenesis induced by glucocorticoid in rabbits[J].Acta Radiol, 2016, 57(6):701-707.
|
[16] |
KALPAKCIOGLU BB, ENGELKE K, GENANT HK. Advanced imaging assessment of bone fragility in glucocorticoid-induced osteoporosis[J].Bone, 2011, 48(6):1221-1231.
|
[17] |
QUARLES LD. Prednisone-induced osteopenia in beagles: variable effects mediated by differential suppression of bone formation[J]. Am J Physiol,1992, 263(1):136-141.
|
[18] |
CHAVASSIEUX P, BUFFET A, VERGNAUD P, et al. Short-term effects of corticosteroids on trabecular bone remodeling in old ewes[J].Bone, 1997,20(5):451-455.
|
[19] |
SCHOLZ-AHRENS KE, DELLING G, STAMPA B, et al. Glucocorticosteroid-induced osteoporosis in adult primiparous Gottingen miniature pigs: effects on bone mineral and mineral metabolism[J].Am J Physiol Endocrinol Metab, 2007, 293(1):385-395.
|
[20] |
PASQUALETTI S, CONGIU T, BANFI G, et al. Alendronate rescued osteoporotic phenotype in a model of glucocorticoid-induced osteoporosis in adult zebrafish scale[J].Int J Exp Pathol, 2015, 96(1):11-20.
|
[21] |
BARRETT R, CHAPPELL C, QUICK M, et al. A rapid, high content, in vivo <\i>model of glucocorticoid-induced osteoporosis[J].Biotechnol J, 2006, 1(6):651-655.
|
[22] |
DE VRIEZE E, VAN KESSEL MA, PETERS HM, et al. Prednisolone induces osteoporosis-like phenotype in regenerating zebrafish scales[J].Osteoporos Int, 2014, 25(2):567-578.
|
[23] |
SALBACH-HIRSCH J, SAMSONOV SA, HINTZE V, et al. Structural and functional insights into sclerostin-glycosaminoglycan interactions in bone[J]. Biomaterials, 2015, 67:335-345.
|
[24] |
WEI X, WU W, LI L, et al. Bone morphogenetic proteins 2/4 are upregulated during the early development of vascular calcification in chronic kidney disease[J]. Biomed Res Int, 2018, 2018:8371604.
|
[25] |
YIN Q, WANG J, FU Q, et al. CircRUNX2 through has-miR-203 regulates RUNX2 to prevent osteoporosis[J]. J Cell Mol Med, 2018,22(12):6112-6121.
|